GlaxoSmithKline Pharmaceuticals Limited reports a change in its board or management
In short
GlaxoSmithKline Pharmaceuticals Limited informed the exchange about a change in the company’s auditors. In simple terms, the company is replacing its auditors, which affects who reviews its accounts. No figures, units, scheme names, or deadlines were given in the notice.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.